• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomePatient VoiceWhen clinical trials are compromised

When clinical trials are compromised

Musa Mayer

1 March 2006 Patient Voice 0

Number 11

Download pdf article

Advocates for early access to unproven treatments may believe they are helping patients, but their actions can put current patients at risk and deny future patients the knowledge they need to make evidence-based treatment decisions, argues Musa Mayer.

Download full article

  • breast cancer
  • clinical trials
  • treatment decisions
Previous article
Next article

Related Articles

Spotlight on

Lungscape: a living lung laboratory

Spotlight on 1 November 2012 0
Featured

Breasts, cancer, and relationships: changing attitudes in central and eastern Europe

Featured, Spotlight on 26 November 2018 0
News

Linking DNA methylation to Aspirin use and breast cancer survival

News 2 September 2019 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy